Understanding the veterinary antibiotic flow in Malawi: complexities, gaps and needs.
Amos Lucky Mhone1,2, Dishon M Muloi1,3, Arshnee Moodley1,2
1Animal and Human Health Program, International Livestock Research Institute, Nairobi, Kenya.
Frontiers in Veterinary Science
|December 5, 2024
Summary
Veterinary antibiotic access for Malawian farmers is hindered by distribution challenges and poor handling practices. Strengthening regulatory oversight and public-private partnerships is crucial for responsible antibiotic use and improved animal health pharmacovigilance.
Area of Science:
- Veterinary Medicine
- Animal Health
- Pharmacovigilance
Background:
- Veterinary antibiotics are vital for animal health and welfare.
- Small-scale farmers in Malawi experience significant barriers to accessing these essential medicines, including limited availability, high costs, and geographical distance to retailers.
Purpose of the Study:
- To map the veterinary antibiotic distribution chain in Malawi.
- To examine the governance structures within this chain.
- To analyze access and usage practices among various stakeholders.
Main Methods:
- Employed a mixed-methods approach.
- Conducted focus group discussions (n=15), key informant interviews (n=6), and individual interviews (n=189).
Main Results:
- Identified key stakeholders: regulators, manufacturers, wholesalers, clinics, retailers, practitioners, and farmers.
- Observed both formal and informal distribution pathways, alongside improper storage and disposal of antibiotics.
- Highlighted a lack of training for veterinary medicine shop attendants and regulatory gaps, including coordination issues and overlapping mandates.
Conclusions:
- Regulatory agencies must enhance oversight and training on antibiotic stewardship.
- Public-private partnerships are needed to manage informal distribution channels effectively.
- A multi-sectoral approach is essential for responsible veterinary antibiotic use and improved pharmacovigilance.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Antibiotic Selection
52.3K
Overview
52.3K
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K


